e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports
François Parquin, Elise Cuquemelle, Eve Camps, Jérôme Devaquet, Mathilde Phillips Houllbracq, Edouard Sage, Olivier Brugière, Morgan Le Guen, Elisabeth Longchampt, Stéphanie Malard, Clément Picard, Jean Luc Taupin, Antoine Roux
Source:
Eur Respir J, 55 (4) 1902027; 10.1183/13993003.02027-2019
Journal Issue:
April
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
François Parquin, Elise Cuquemelle, Eve Camps, Jérôme Devaquet, Mathilde Phillips Houllbracq, Edouard Sage, Olivier Brugière, Morgan Le Guen, Elisabeth Longchampt, Stéphanie Malard, Clément Picard, Jean Luc Taupin, Antoine Roux. C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports. Eur Respir J, 55 (4) 1902027; 10.1183/13993003.02027-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Immunosuppressive therapy after human lung transplantation
Source: Eur Respir J 2004; 23: 159-171
Year: 2004
A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010
Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003
Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001
Rapamycin in patients with chronic lung rejection
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005
Lymphoma's and rejection after lung transplantation: balancing the immunosuppression
Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression
Year: 2005
Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003
Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008
Dose-dependent pro- or anti-proliferative effects of calcineurin inhibitors in bronchiolitis obliterans following allogeneic stem cell transplantation
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients
Source: Eur Respir J, 53 (5) 1900055; 10.1183/13993003.00055-2019
Year: 2019
II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up
Source: Eur Respir J 2004; 24: Suppl. 48, 180s
Year: 2004
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016
The murine orthotopic single lung transplantation model for chronic rejection: work in progress?
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018
Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
Source: Eur Respir J 2014; 43: 221-232
Year: 2004
Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept